|
|
Hypoxia Promotes the Molecular Mechanism of High-Altitude Polycythemia by Mediating the Demethylation of Hepcidin mRNA through HIF-1α |
BAI Jie, HUANG He, ZHANG Lian, et al |
The 940th Hospital of Joint Logistics Support Force, Gansu Lanzhou 730030, China |
|
|
Abstract Objective: To investigate the roles of HIF-1α and Hepcidin in the pathogenesis of high-altitude polycythemia (HAP).Methods: Peripheral blood hemoglobin concentration [Hb], hemoglobin mass (Hbmass), blood volume, and peripheral blood O2 saturation (SpO2) were measured in subjects with high-altitude polycythemia (HAE group), healthy individuals residing at the same high altitude (HH group), and healthy individuals born at high altitude but residing at low altitude for over 2 years (LH group). ELISA was used to determine the levels of HIF-1α and Hepcidin in peripheral blood serum. HepG2 cells were cultured under hypoxia in vitro, with experimental groups including Control and Hypoxia groups. The expression levels of HIF-1α and Hepcidin mRNA and protein were measured. m6A content analysis, RNA immunoprecipitation (RIP), dual-luciferase reporter assay, and mRNA stability analysis were used to explore the molecular mechanisms by which HIF-1α mediates m6A demethylation of Hepcidin mRNA.Results: Compared with the LH group, the HH group had increased levels of [Hb], Hbmass, and blood volume, and decreased SpO2; compared with the HH group, the HAE group had increased levels of [Hb], Hbmass, and blood volume, and decreased SpO2 (P<0.05). Compared with the Control group, the Hypoxia group showed increased relative expression levels of HIF-1α mRNA and protein, and decreased relative expression levels of Hepcidin mRNA and protein in HepG2 cells (P<0.05). The m6A (%) level in the Hypoxia group was lower than in the Control group (P<0.05). mRNA stability analysis showed that the relative expression level of Hepcidin mRNA in the Hypoxia group was lower than in the Control group (P<0.05). Dual-luciferase reporter assay showed that relative luciferase activity was higher in HepG2 cells co-transfected with Hepcidin 3'-UTR and HIF-1α shRNA compared to cells co-transfected with Hepcidin 3'-UTR and shRNA NT (P<0.05). RIP results showed that the enrichment level of Hepcidin 3'-UTR was higher in the FTO Ab group compared to the IgG group (P<0.05).Conclusion: Hypoxia-induced upregulation of HIF-1α mediates the demethylation of Hepcidin mRNA, contributing to the progression of high-altitude polycythemia.
|
|
|
|
|
[1] Villafuerte FC,Simonson TS,Bermudez D,et al.High-altitude erythrocytosis: mechanisms of adaptive and maladaptive responses[J].Physiology (Bethesda),2022,37(4):175-186.
[2] 吴萍,赵艳霞,李永平,等.基于因子分析的高原红细胞增多症中医证候量化诊断研究[J].西部中医药,2023,36(10):104-111.
[3] 何鑫,张耐辉,鲍海华.多模态影像技术在高原红细胞增多症中的研究进展[J].磁共振成像,2023,14(4):198-202.
[4] Sato T,Takeda N.The roles of HIF-1α signaling in cardiovascular diseases[J].Cardiol,2023,81(2):202-208.
[5] Karthiya R,Khandelia P.m6A RNA methylation: ramifications for gene expression and human health[J].Mol Biotechnol,2020,62(10):467-484.
[6] Villafuerte FC,Corante N.Chronic mountain sickness: clinical aspects,etiology,management,and treatment[J].High Alt Med Biol,2018,17(2):61-69.
[7] Stembridge M,Williams AM,Gasho C,et al.The overlooked significance of plasma volume for successful adaptation to high altitude in sherpa and andean natives[J].Proc Natl Acad Sci USA,2019,116(33):16177-16179.
[8] Cao Y,Wang H,Hu S,et al.PICK1 modulates glycolysis and angiogenesis of hypoxic endothelial cells by regulating iron homeostasis[J].Mol Cell Biochem,2023,479(5):1297-1312.
[9] Jiang X,Liu B,Nie Z,et al.The role of m6A modification in the biological functions and diseases[J].Signal Transduct Target Ther,2021,6(1):74.
[10] Qin Y,Li L,Luo E,et al.Role of m6A RNA methylation in cardiovascular disease (Review)[J].Int Mol Med,2020,46(6):1958-1972.
[11] Yu F,Wei J,Cui X,et al.Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response[J].Nucleic Acids Res,2021,49(10):5779-5797.
[12] Azzam SK,Alsafar H,Sajini AA.FTO m6A demethylase in obesity and cancer:implications and underlying molecular mechanisms[J].Int Mol Sci,2022,23(7):3800. |
|
|
|